Our xenograft mouse model studies demonstrate that VERU-111 (50 μg/mice) effectively inhibits tumor growth with concomitant inhibition of βI, βIII and βIV tubulins and restoring expression of miR-200c. The gene discussed is CACNA1A; the disease is neoplasm.